Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ) Investor Relations Material

Overview

Sunesis is a biopharmaceutical company that is currently in the clinical stage of development. The company's main goal is to discover, develop, and ultimately commercialize new small molecule therapeutics that can be used for a variety of medical needs, including oncology. With a focus on innovation and research, Sunesis is poised to make a significant impact in the biopharmaceutical industry.

Annual Reports

Frequently Asked Questions

What is Sunesis Pharmaceuticals, Inc.'s ticker?

Sunesis Pharmaceuticals, Inc.'s ticker is SNSS

What exchange is Sunesis Pharmaceuticals, Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Sunesis Pharmaceuticals, Inc.'s headquarters?

They are based in South San Francisco, California

How many employees does Sunesis Pharmaceuticals, Inc. have?

There are 51-200 employees working at Sunesis Pharmaceuticals, Inc.

What is Sunesis Pharmaceuticals, Inc.'s website?

It is http://www.sunesis-pharma.com

What type of sector is Sunesis Pharmaceuticals, Inc.?

Sunesis Pharmaceuticals, Inc. is in the Healthcare sector

What type of industry is Sunesis Pharmaceuticals, Inc.?

Sunesis Pharmaceuticals, Inc. is in the Biotechnology industry

Who are Sunesis Pharmaceuticals, Inc.'s peers and competitors?

The following five companies are Sunesis Pharmaceuticals, Inc.'s industry peers:

- Aridis Pharmaceuticals Inc.

- Achieve Life Sciences

- Arena Pharmaceuticals

- Ligand Pharmaceuticals

- EverGen Infrastructure